Mechanism for the protective effect of resveratrol against oxidative stress-induced neuronal death

Free Radical Biology and Medicine

Volumn 49, Issue 5, 2010, Pages 800-813

  Fukui, Masayuki ^a   Choi, Hye Joung ^a   Zhu Bao Ting, B T ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

Free radicals; HT22; Oxidative stress; PI3K Akt signaling pathway; Resveratrol; Superoxide dismutase

Indexed keywords

BETA CATENIN; GLUTAMIC ACID; GLYCOGEN SYNTHASE KINASE 3BETA; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; RESVERATROL; SUPEROXIDE DISMUTASE;

ANIMAL CELL; ARTICLE; CELL DEATH; CONTROLLED STUDY; CYTOTOXICITY; FLOW CYTOMETRY; HIPPOCAMPUS; MITOCHONDRION; MOUSE; NERVE CELL; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCAVENGING SYSTEM;

EID: 77955096088     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2010.06.002     Document Type: Article

References (69)

1. Coyle J.T., Puttfarcken P. Oxidative stress, glutamate, and neurodegenerative disorders. Science 1993, 262:689-695.
2. Blandini F., Porter R.H., Greenamyre J.T. Glutamate and Parkinson's disease. Mol. Neurobiol. 1996, 12:73-94.
3. Choi D.W. Glutamate neurotoxicity and diseases of nervous system. Neuron 1988, 1:623-634.
4. Choi D.W. Excitotoxic cell death. J. Neurobiol. 1992, 23:1261-1276.
5. Murphy T.H., Miyamoto M., Sastre A., Schnaar R.L., Coyle J.T. Glutamate toxicity in neuronal cell line involves inhibition of cystine transport leading to oxidative stress. Neuron 1989, 2:1547-1558.
6. Froissard P., Duval D. Cytotoxic effects of glutamic acid on PC12 cells. Neurochem. Int. 1994, 24:485-493.
7. Davis J.B., Maher P. Protein kinase C activation inhibits glutamate-induced cytotoxicity in a neuronal cell line. Brain Res. 1994, 652:169-173.
8. Maher P., Davis J.B. The role of monoamine metabolism in oxidative glutamate toxicity. J. Neurosci. 1996, 16:6394-6401.
9. Murphy T.H., Schnaar R.L., Coyle J.T. Immature cortical neurons are uniquely sensitive to glutamate toxicity by inhibition of cystine uptake. FASEB J. 1990, 4:1624-1633.
10. Erdö S.L., Michler A., Wolff J.R., Tytko H. Lack of excitotoxic cell death in serum-free cultures of rat cerebral cortex. Brain Res. 1990, 526:328-332.
11. Oka A., Belliveau M.J., Rosenberg P.A., Volpe J.J. Vulnerability of oligodendroglia to glutamate: pharmacology, mechanisms, and prevention. J. Neurosci. 1993, 13:1441-1453.
12. Tan S., Wood M., Maher P. Oxidative stress induces a form of programmed cell death with characteristics of both apoptosis and necrosis in neuronal cells. J. Neurochem. 1998, 71:95-105.
13. Tan S., Schubert D., Maher P. Oxitosis: a novel form of programmed cell death. Curr. Top. Med. Chem. 2001, 1:497-506.
14. Morimoto B.H., Koshland D.E. Induction and expression of long- and short-term neurosecretory potentiation in a neural cell line. Neuron 1990, 5:875-880.
15. Fukui M., Song J.H., Choi J.Y., Choi H.J., Zhu B.T. Mechanism of glutamate-induced necrosis and apoptosis in cultured HT22 cells. Eur. J. Pharmacol. 2009, 617:1-11.
16. Moosmann B., Behl C. The antioxidant neuroprotective effects of estrogens and phenolic compounds are independent from their estrogenic properties. Proc. Natl. Acad. Sci. USA 1999, 96:8867-8872.
17. Ishige K., Schubert D., Sagara Y. Flavonoids protect neuronal cells from oxidative stress by three distinct mechanisms. Free Radic. Biol. Med. 2001, 30:433-446.
18. Miyamoto M., Murphy T.H., Schnaar R.L., Coyle J.T. Antioxidants protect glutamate-induced cytotoxicity in a neuronal cell line. J. Pharmacol. Exp. Ther. 1989, 250:1132-1140.
19. Chen C.Y., Jang J.H., Li M.H., Surh Y.J. Resveratrol upregulates heme oxygenase-1 expression via activation of NF-E2-related factor 2 in PC12 cells. Biochem. Biophys. Res. Commun. 2005, 331:993-1000.
20. Vieira de Almeida L.M., Piñeiro C.C., Leite M.C., Brolese G., Leal R.B., Gottfried C., Gonçalves C.A. Protective effects of resveratrol on hydrogen peroxide induced toxicity in primary cortical astrocyte cultures. Neurochem. Res. 2008, 33:8-15.
21. Kopp P. Resveratrol, a phytoestrogen found in red wine: a possible explanation for the conundrum of the 'French paradox'?. Eur. J. Endocrinol. 1998, 138:619-620.
22. Sobolev V.S., Cole R.J. Trans-resveratrol contain in commercial peanuts and peanut products. J. Agric. Food Chem. 1999, 47:1435-1439.
23. Roldan A., Palacios V., Caro I., Perez L. Resveratrol content of Palomino fino grapes: influence of vintage and fungal infection. J. Agric. Food Chem. 2003, 51:1464-1468.
24. Hanaichi T., Sato T., Iwamoto T., Malavasi-Yamashiro J., Hoshino M., Mizuno N. A stable lead by modification of Sato's method. J. Electron Microsc. 1986, 35:304-306.
25. 2 regulates the angiogenic phenotype via PTEN oxidation. J. Biol. Chem. 2005, 280:16916-16924.
26. Zhou R., Fukui M., Choi H.J., Zhu B.T. Induction of a reversible, non-cytotoxic S-phase delay by resveratrol: implications for a mechanism of lifespan prolongation and cancer promotion. Br. J. Pharmacol. 2009, 158:462-474.
27. Raynal P., Pollard H.B. Annexins: the problem of assessing the biological role for a gene family of multifunctional calcium and phospholipids-binding proteins. Biochim. Biophys. Acta 1994, 1197:63-93.
28. Vermes I., Haanen C., Steffens-Nakken H., Reutelingsperger C. A novel assay for apoptosis: flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labeled annexin V. J. Immunol. Methods 1995, 184:39-51.
29. van Engeland M., Ramaekers F.C., Schutte B., Reutelingsperger C. A novel assay to measure loss of plasma membrane asymmetry during apoptosis of adherent cells in culture. Cytometry 1996, 24:131-139.
30. Koning A.J., Lum P.Y., Williams J.M., Wright R. DiOC6 staining reveals organelle structure and dynamics in living yeast cells. Cell Motil. Cytoskeleton 1993, 25:111-128.
31. Wilson L., Yang Q., Szustakowski J.D., Gullicksen P.S., Halse R. Pyruvate induces mitochondrial biogenesis by a PGC-1α-independent mechanism. Am. J. Physiol. Cell Physiol. 2007, 292:C1599-C1605.
32. Stojanovic S., Sprinz H., Brede O. Efficacy and mechanism of the antioxidant action of trans-resveratrol and its analogues in the radical liposome oxidation. Arch. Biochem. Biophys. 2001, 391:79-89.
33. Clement M.V., Hirpara J.L., Chawdhury S.H., Pervaiz S. Chemopreventive agent resveratrol, a natural product derived from grapes, triggers CD95 signaling-dependent apoptosis in human tumor cells. Blood 2000, 92:996-1002.
34. Gill C., Walsh S.E., Morrissey C., Fitzpatrick J.M., Watson R.W.G. Resveratrol sensitizes androgen independent prostate cancer cells to death-receptor mediated apoptosis through multiple mechanisms. Prostate 2007, 67:1641-1653.
35. Su J.L., Lin M.T., Hong C.C., Chang C.C., Shiah S.G., Wu C.W., Chen S.T., Chau Y.P., Kuo M.L. Resveratrol induces FasL-related apoptosis through Cdc42 activation of ASK1/JNK-dependent signaling pathway in human leukemia HL-60 cells. Carcinogenesis 2005, 26:1-10.
36. Nakagawa H., Kiyozuka Y., Uemura Y., Senzaki H., Shikata N., Hioki K., Tsubura A. Resveratrol inhibits human breast cancer cell growth and may mitigate the effect of linoleic acid, a potent breast cancer cell stimulator. J. Cancer Res. Clin. Oncol. 2001, 127:258-264.
37. Aziz M.H., Nihal M., Fu V.X., Jarrard D.F., Ahmad N. Resveratrol-caused apoptosis of human prostate carcinoma LNCaP cells in mediated via modulation of phosphatidylinositol 3-kinase/Akt pathway and Bcl-2 family proteins. Mol. Cancer Ther. 2006, 5:1335-1341.
38. Pozo-Guisado E., Merino J.M., Mulero-Navarro S., Lorenzo-Benayas M.J., Centeno F., Alvarez-Barrientos A., Fernandez-Salguero P.M. Resveratrol-induced apoptosis in MCF-7 human breast cancer cells involves a caspase-independent mechanism with down-regulation of Bcl-2 and NF-κB. Int. J. Cancer 2005, 115:74-84.
39. Alkhalaf M. Resveratrol-induced growth inhibition in MDA-MB-231 breast cancer cells is associated with mitogen-activated protein kinase signaling and protein translation. Eur. J. Cancer Prev. 2007, 16:334-341.
40. She Q.B., Bode A.M., Ma W.Y., Chen N.Y., Dong Z. Resveratrol-induced activation of p53 and apoptosis is mediated by extracellular-signal-regulated protein kinase and p38 kinase. Cancer Res. 2001, 61:1604-1610.
41. 2-terminal kinases in resveratrol-induced activation of p53 and apoptosis. Mol. Carcinog. 2002, 33:244-250.
42. Liu X., Rubin J.S., Kimmel A.R. Rapid, Wnt-induced changes in GSK3beta associations that regulate beta-catenin stabilization are mediated by Galpha proteins. Curr. Biol. 2005, 15:1989-1997.
43. Essers M.A.G., de Vries-Smits L.M.M., Barker N., Polderman P.E., Burgering B.M.T., Korswagen H.C. Functional interaction between β-catenin and FOXO in oxidative stress signaling. Science 2005, 308:1181-1184.
44. Fukui M., Zhu B.T. Mitochondrial superoxide dismutase SOD2, but not cytosolic SOD1, plays a critical role in protection against glutamate-induced oxidative stress and cell death in HT22 neuronal cells. Free Radic. Biol. Med. 2010, 48:821-830.
45. Robb E.L., Page M.M., Wiens B.E., Stuart J.A. Molecular mechanisms of oxidative stress resistance induced by resveratrol: specific and progressive induction of MnSOD. Biochem. Biophys. Res. Commun. 2008, 367:406-412.
46. Vlahos C.J., Matter W.F., Hui K.Y., Brown R.F. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J. Biol. Chem. 1994, 269:5241-5248.
47. Walker E.H., Pacold M.E., Perisic O., Stephens L., Hawkins P.T., Wymann M.P., Williams R.L. Structural determinants of phosphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin, and staurosporine. Mol. Cell 2000, 6:909-919.
48. Alvarez A.R., Godoy J.A., Mullendorff K., Olivares G.H., Bronfman M., Inestrosa N.C. Wnt-3α overcomes β-amyloid toxicity in rat hippocampal neurons. Exp. Cell Res. 2004, 297:186-196.
49. Liu C., Li Y., Semenov M., Han C., Baeg G.H., Tan Y., Zhang Z., Lin X., He X. Control of β-catenin phosphorylation/degradation by a dual-kinase mechanism. Cell 2002, 108:837-847.
50. Moon R.T., Bowerman B., Boutros M., Perrimon N. The promise and perils of Wnt signaling through β-catenin. Science 2002, 296:1644-1646.
51. Willert K., Brown J.D., Danenberg E., Duncan A.W., Weissman I.L., Reya T., Yates J.R., Nusse R. Wnt proteins are lipid-modified and can act as stem cell growth factors. Nature 2003, 423:448-452.
52. Hashimoto M., Sagara Y., Langford D., Everall I.P., Mallory M., Everson A., Digicaylioglu M., Masliah E. Fibroblast growth factor 1 regulates signaling via the glycogen synthase kinase-3β pathway. J. Biol. Chem. 2002, 277:32985-32991.
53. Halliwell B., Gutteridge J.M.C. Protection against oxidants in biological systems: the superoxide theory of oxygen toxicity 1995, 86-187. Free Radicals in Biology and Medicine, Oxford, UK.
54. Silva J.P., Shabalina I.G., Dufour E., Petrovic N., Backlund E.C., Hultenby K., Wibom R., Nedergaard J., Cannon B., Larsson N.G. SOD2 overexpression: enhanced mitochondrial tolerance but absence of effect on UCP activity. EMBO J. 2005, 24:4061-4070.
55. Ookawara T., Imazeki N., Matsubata O., Kizaki T., Oh-Ishi S., Nakao C., Sato Y., Ohno H. Tissue distribution of immunoreactive mouse extracellular superoxide dismutase. Am. J. Physiol. Cell Physiol. 1998, 275:840-847.
56. Hinerfeld D., Traini M.D., Weinberger R.P., Cochran B., Doctrow S.R., Harry J., Melov S. Endogenous mitochondrial oxidative stress: neurodegeneration, proteomic analysis, specific respiratory chain defects, and efficacious antioxidant therapy in superoxide dismutase 2 null mice. J. Neurochem. 2004, 88:657-667.
57. Vincent A.M., Russell J.W., Sullivan K.A., Backus C., Hayes J.M., McLean L.L., Feldman E.L. SOD2 protects neurons from injury in cell culture and animal models of diabetic neuropathy. Exp. Neurol. 2007, 208:216-227.
58. Horovitz-Fried M., Cooper D.R., Patel N.A., Cipok M., Brand C., Bak A., Inbar A., Jacob A.I., Sampson S.R. Insulin rapidly upregulates protein kinase Cδ gene expression in skeletal muscle. Cell Signalling 2006, 18:183-193.
59. Horovitz-Fried M., Brutman-Barazani T., Kesten D., Sampson S.R. Insulin increases nuclear protein kinase Cδ in L6 skeletal muscle cells. Endocrinology 2008, 149:1718-1727.
60. 2 in cells and thereby their biological state. Free Radic. Biol. Med. 2006, 41:1338-1350.
61. Kaizaki A., Tanaka S., Ishige K., Numazawa S., Yoshida T. The neuroprotective effect of heme oxygenase (HO) on oxidative stress in HO-1 siRNA-transfected HT22 cells. Brain Res. 2006, 1108:39-44.
62. Otterbein L.E., Choi A.M. Heme oxygenase: colors of defense against cellular stress. Am. J. Physiol. Lung Cell Mol. Physiol. 2000, 279:1029-1037.
63. Stocker R., Yamamoto Y., McDonagh A.F., Glazer A.N., Ames B.N. Bilirubin is an antioxidant of possible physiological importance. Science 2000, 235:1043-1045.
64. Stanciu M., Wang Y., Kentor R., Burke N., Watkins S., Kress G., Reynolds I., Klann E., Angiolieri M.R., Johnson J.W., DeFranco D.B. Persistent activation of ERK contributes to glutamate-induced oxidative toxicity in a neuronal cell line and primary cortical neuron cultures. J. Biol. Chem. 2000, 275:12200-12206.
65. Sun A.Y., Chen Y.M. Oxidative stress and neurodegenerative disorders. J. Biomed. Sci. 1998, 5:401-414.
66. Dawson R., Beal M.F., Bondy S.C., Di Monte D.A., Isom G.E. Excitotoxins, aging, and environmental neurotoxins: implications for understanding human neurodegenerative diseases. Toxicol. Appl. Pharmacol. 1995, 134:1-17.
67. Wang Q., Yu S., Simonyi A., Sun G.Y., Sun A.Y. Kainic acid-mediated excitotoxicity as a model for neurodegeneration. Mol. Neurobiol. 2005, 31:3-16.
68. Wang Q., Yu S., Simonyi A., Rottinghaus G., Sun G.Y., Sun A.Y. Resveratrol protects against neurotoxicity induced by kainic acid. Neurochem. Res. 2004, 29:2105-2112.
69. Robb E.L., Winkelmolen L., Visanji N., Brotchie J., Stuart J.A. Dietary resveratrol administration increases MnSOD expression and activity in mouse brain. Biochem. Biophys. Res. Commun. 2008, 372:254-259.